Viral driven epigenetic events alter the expression of cancer-related genes in Epstein-Barr-virus naturally infected Burkitt lymphoma cell lines
10.1038/s41598-017-05713-2 · doi-reference
Diagnosing Burkitt Lymphoma in Sub-Saharan Africa by Sequencing of Circulating Tumor DNA: A Comparative Microcosting Study
10.1016/j.vhri.2025.101113 · doi-reference
Haematological malignancies in sub-Saharan Africa: east Africa as an example for improving care
10.1016/s2352-3026(21)00198-8 · doi-reference
Circulating tumour DNA and CT monitoring in patients with untreated diffuse large B-cell lymphoma: a correlative biomarker study
10.1016/s1470-2045(15)70106-3 · doi-reference
Circulating Tumor DNA Measurements As Early Outcome Predictors in Diffuse Large B-Cell Lymphoma
10.1200/jco.2018.78.5246 · doi-reference
Genetic modification of primary human B cells to model high-grade lymphoma
10.1038/s41467-019-12494-x · doi-reference
Relevance of ID3-TCF3-CCND3 pathway mutations in pediatric aggressive B-cell lymphoma treated according to the non-Hodgkin Lymphoma Berlin-Frankfurt-Münster protocols
10.3324/haematol.2016.156885 · doi-reference
PDXGEM: patient-derived tumor xenograft-based gene expression model for predicting clinical response to anticancer therapy in cancer patients
10.1186/s12859-020-03633-z · doi-reference
A human breast cancer-derived xenograft and organoid platform for drug discovery and precision oncology
10.1038/s43018-022-00337-6 · doi-reference
Pan-Cancer Pharmacogenomic Analysis of Patient-Derived Tumor Cells Using Clinically Relevant Drug Exposures
10.1158/1535-7163.mct-22-0486 · doi-reference
Data augmentation and multimodal learning for predicting drug response in patient-derived xenografts from gene expressions and histology images
10.3389/fmed.2023.1058919 · doi-reference
Generation of Tumor-Reactive T Cells by Co-culture of Peripheral Blood Lymphocytes and Tumor Organoids
10.1016/j.cell.2018.07.009 · doi-reference
Burkitt lymphoma with a granulomatous reaction: an M1/Th1-polarised microenvironment is associated with controlled growth and spontaneous regression
10.1111/his.14391 · doi-reference
Tumor microenvironment of Burkitt lymphoma: different immune signatures with different clinical behavior
10.1182/bloodadvances.2023011506 · doi-reference
Immune disparities in the TME of EBV+ and EBV- BL: role of ROS generation pathways and platelet activation
10.1182/bloodadvances.2025018518 · doi-reference
A human lymphoma organoid model for evaluating and targeting the follicular lymphoma tumor immune microenvironment
10.1016/j.stem.2024.01.012 · doi-reference
Organoid Modeling of the Tumor Immune Microenvironment
10.1016/j.cell.2018.11.021 · doi-reference
A Living Biobank of Breast Cancer Organoids Captures Disease Heterogeneity
10.1016/j.cell.2017.11.010 · doi-reference
Development of patient-derived lymphomoids with preserved tumor architecture for lymphoma therapy screening
10.1038/s41467-024-55098-w · doi-reference
Co-transplantation of human hematopoietic stem cells and human breast cancer cells in NSG mice: a novel approach to generate tumor cell specific human antibodies
10.4161/mabs.29111 · doi-reference
Development and function of human innate immune cells in a humanized mouse model
10.1038/nbt.2858 · doi-reference
Development of a human adaptive immune system in cord blood cell-transplanted mice
10.1126/science.1093933 · doi-reference
EBNA2-deleted Epstein-Barr virus (EBV) isolate, P3HR1, causes Hodgkin-like lymphomas and diffuse large B cell lymphomas with type II and Wp-restricted latency types in humanized mice
10.1371/journal.ppat.1008590 · doi-reference
The Use of the Humanized Mouse Model in Gene Therapy and Immunotherapy for HIV and Cancer
10.3389/fimmu.2018.00746 · doi-reference
Generation of Human Immunosuppressive Myeloid Cell Populations in Human Interleukin-6 Transgenic NOG Mice
10.3389/fimmu.2018.00152 · doi-reference
Humanized hemato-lymphoid system mice
10.3324/haematol.2014.115212 · doi-reference
Modification of EBV Associated Lymphomagenesis and Its Immune Control by Co-Infections and Genetics in Humanized Mice
10.3389/fimmu.2021.640918 · doi-reference
Modeling EBV infection and pathogenesis in new-generation humanized mice
10.1038/emm.2014.88 · doi-reference
Generation of functional human T-cell subsets with HLA-restricted immune responses in HLA class I expressing NOD/SCID/IL2r gamma(null) humanized mice
10.1073/pnas.1000475107 · doi-reference
Priming of protective T cell responses against virus-induced tumors in mice with human immune system components
10.1084/jem.20081720 · doi-reference
Complex genetic and histopathological study of 15 patient-derived xenografts of aggressive lymphomas
10.1038/s41374-022-00784-w · doi-reference
B-Cell Lymphoma Patient-Derived Xenograft Models Enable Drug Discovery and Are a Platform for Personalized Therapy
10.1158/1078-0432.ccr-16-2703 · doi-reference
Endemic Burkitt lymphoma avatar mouse models for exploring inter-patient tumor variation and testing targeted therapies
10.26508/lsa.202101355 · doi-reference
Patient-derived xenograft models of ALK+ ALCL reveal preclinical promise for therapy with brigatinib
10.1111/bjh.18953 · doi-reference
Paediatric Burkitt lymphoma patient-derived xenografts capture disease characteristics over time and are a model for therapy
10.1111/bjh.17043 · doi-reference
Humanized Mouse Models of Clinical Disease
10.1146/annurev-pathol-052016-100332 · doi-reference
Progress towards the WHO Global Initiative for Childhood Cancer target of 60% 5-year survival for all childhood cancers combined, 1990-2019 (CONCORD-4): a Cancer Survival Index derived for 68 countries by analysis of individual records for 613 021 children from 307 population-based cancer registries
10.1016/s0140-6736(26)00189-3 · doi-reference
Global burden of cancer in children and adolescents aged 0-19 years, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023
10.1016/s0140-6736(26)00200-x · doi-reference
African Burkitt's lymphoma: could collaboration with HIV-1 and malaria programmes reduce the high mortality rate?
10.1016/s0140-6736(10)60134-1 · doi-reference
Is liquid biopsy a cost-effective method to diagnose Burkitt Lymphoma in children and young adults? A health economic evaluation in Tanzania
10.1186/s12916-026-04694-2 · doi-reference
